Research study Program year 2023 Source: CMS Open Payments

Open-Label Phase 1 Study of SGN-B7H4V for Solid Tumors

Research payments

$8,817,848

1,105 payments

Through program year 2023, $8,817,848 in research payments was reported against Open-Label Phase 1 Study of SGN-B7H4V for Solid Tumors, across 1,105 payments, paid by Seattle Genetics, Inc..

Paid by: Seattle Genetics, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2023	Research	$6,608,974	749
2022	Research	$2,208,874	356

Breakdown

Who paid Research payments · program years 2022–2023

Seattle Genetics, Inc. $8,817,848 1,105 payments

Who received the money Research payments · program years 2022–2023

Florida Cancer Specialists Organisation paid for research $1,483,018 242 payments
Sarah Cannon Research Institute Organisation paid for research $1,200,603 141 payments
Cancer & Hematology Centers - Start Midwest Organisation paid for research $1,131,175 182 payments
Healthone Clinic Services Neurosciences Organisation paid for research $1,070,880 152 payments
Start Mountain Region Organisation paid for research $834,766 143 payments
Mayo Clinic - Florida Organisation paid for research $815,183 51 payments
Community Health Network Organisation paid for research $642,782 8 payments
Start Center For Cancer Care Organisation paid for research $609,318 115 payments
Northwestern University Organisation paid for research $373,717 7 payments
University of Colorado Organisation paid for research $358,081 55 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.